© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Ceftazidime Sodium Carbonate comes from a blend of ceftazidime and sodium carbonate, serving as a vital raw material in chemical manufacturing and pharmaceutical synthesis. Recognized under the HS Code 29419090, this substance links directly to the cephalosporin family, housing strong antibacterial properties. Its molecular formula lands at C22H21N6O7S2 · Na2CO3, giving it a molar mass of about 636.5 g/mol, showing a clear, defined chemical structure that supports its specific function in drug development. The mixture forms a reliable product for compounding sterile solutions and offers backbone support for injectable antibiotics.
A close look at pure ceftazidime sodium carbonate reveals dense, crystalline solid matter in either flaky, granulated, or powder form. Sometimes, it turns up as coarse pearls, supplying consistent reactivity. The material generally holds a white or nearly white color with mild, slightly salty undertones due to the sodium carbonate. Small-scale handling often uses solid flakes or loose powder, while industrial production requires careful dissolution into sterile solutions—one of the essential steps for safe pharmaceutical use. A typical solution combines 1 gram of compound per liter of water, delivering a stable, transparent liquid suited for injection or further processing. The density ranges from 1.3 to 1.4 g/cm³ depending on moisture and storage, with bulk density fluctuating where fine powder or flakes have settled. Storage calls for dry, cool conditions away from reactive contaminants. One key detail from years working with raw chemicals is the importance of handling these substances in controlled, contamination-free zones, since trace contaminants can easily alter pharmaceutical-grade material.
Ceftazidime sodium carbonate exhibits high solubility in water, forming a clear solution without heavy residue—essential for sterile applications. Its structure resists breakdown when protected from light and humidity, which matters for shelf life. Solid forms can cake with excess moisture, so dry storage remains crucial. Common laboratory experience shows how exposure to air or water shortens shelf life, which adds up in costs across busy manufacturing labs. Users need to wear PPE because, although not extremely hazardous under general use, it can cause mild skin or eye irritation and respiratory problems if inhaled as powder. Its Safety Data Sheet ranks it as a harmful chemical primarily after prolonged, repeated exposure. Responsible operation avoids dust generation, and lab teams learn fast to keep spills contained and use dedicated chemical waste disposal streams.
Pharmaceutical firms rely on ceftazidime sodium carbonate as a core raw material for synthesis of injectable antibiotics effective against Gram-negative bacteria. This reliance shows up in hospital formularies and procurement lists, since ceftazidime stands among the few options for tackling hard-to-treat infections. A steady supply chain for this compound helps prevent shortages during increased demand, and transparency from raw materials to final product matters for batch traceability. Specific applications also stretch into custom compounding for hospital pharmacies, where sterile powder blends get reconstituted for immediate patient use. From direct experience in distribution, keeping granular quality and proper certificates of analysis on hand ensures fewer rejections during regulatory review.
Like many raw materials, ceftazidime sodium carbonate poses risks if handled carelessly. Respiratory exposure to dust increases the risk of allergic reactions, and improper storage may cause chemical degradation or generate hazardous byproducts. This raises workplace safety concerns and impacts product purity. To manage these risks, facilities set up proper air filtration, sealed storage cabinets, and real-time humidity control. Education tackles human error—regular training for lab workers and real stories of mishaps drive home the lesson better than pamphlets. Effective logistics and supply chain transparency help reduce risk of mix-ups or delays that compromise the cold chain.
On a molecular level, ceftazidime sodium carbonate fuses the beta-lactam backbone of ceftazidime with sodium ions, resulting in a solid matrix that stabilizes both the drug and the carbonate base. This configuration supports pharma compounding where pH control and reactivity set the standard for compatibility with patient delivery systems. Manufacturers verify the product through infrared spectroscopy and X-ray diffraction, matching established reference profiles to confirm authenticity before shipment—a regular step that keeps quality problems off the table. Chemists know firsthand the trouble that off-spec batches cause, sometimes halting production for days or weeks.
Growing attention centers on minimizing chemical waste and ensuring safe disposal of ceftazidime sodium carbonate byproducts. Labs and manufacturers look for ways to neutralize leftover solution, turning reactive carbonate into benign sodium salts that pose less risk to water systems. Experience with environmental audits shows how documentation of safe disposal practices reduces regulatory headaches and builds trust with communities nearby production facilities. Some companies now set up take-back or recycling programs for unused batches, aiming to ease the burden on hazardous waste streams and keep raw material costs steady.
Ceftazidime sodium carbonate holds a critical place in chemical and pharmaceutical workflows, with its properties demanding close attention through every stage, from initial synthesis to delivery. Achieving the right balance between consistent supply, rigorous safety, and responsible disposal calls for hands-on experience, practical training, and continued improvement in material handling. Strong documentation, open supply chains, and commitment to environmental protection form the backbone of safe, sustainable chemical use in modern industry.
